Memphis Pharmaceuticals & Chemical Industries's latest marketcap:
As of 07/05/2025, Memphis Pharmaceuticals & Chemical Industries's market capitalization has reached $33.5 M. According to our data, Memphis Pharmaceuticals & Chemical Industries is the 32707th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 33.5 M |
| Revenue (ttm) | 25.78 M |
| Net Income (ttm) | 7.92 M |
| Shares Out | 22.75 M |
| EPS (ttm) | 0.35 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 11/13/2024 |
| Earnings Date | 09/14/2025 |
Memphis Pharmaceuticals & Chemical Industries's yearly market capitalization.
| Date | Market Cap(EGP) | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | 33.5 M | 478.51% | 32707 |
| 12/31/2024 | 293.29 M | -16.86% | 40464 |
| 12/31/2023 | 352.74 M | 252.3% | 36608 |
| 12/29/2022 | 100.12 M | -15.24% | 38875 |
| 12/30/2021 | 118.12 M | 9.95% | 36423 |
| 12/31/2020 | 107.44 M | 102.12% | 33245 |
| 12/31/2019 | 53.16 M | 8.62% | 31572 |
| 12/31/2018 | 48.94 M | -44.97% | 30884 |
| 12/31/2017 | 88.93 M | 43.73% | 29127 |
| 12/29/2016 | 61.88 M | 22.22% | 27533 |
Company Profile
About Memphis Pharmaceuticals & Chemical Industries
Memphis Pharmaceuticals & Chemical Industries is a leading drug holding company specializing in the production and distribution of pharmaceutical products for both human and veterinary use. Operating primarily in Egypt with an international presence, the company has been a trusted name in the industry since its founding in 1940.
Human Health Products
The company offers a diverse range of human health products across multiple therapeutic areas, including:
- Anti-infective
- CNS (Central Nervous System)
- Dermatological
- Cardiovascular system
- Corticosteroid
- Vitamins and minerals
- Musculo-skeletal system
- Analgesic and antipyretic
- Respiratory system
- Genitourinary system
- Alimentary tract and metabolism
- Antihistaminic
- Antiparasites
- Hormones
Animal Health Products
In addition to human pharmaceuticals, Memphis Pharmaceuticals provides veterinary solutions in various forms, such as:
- Powder formulations
- Oral solutions
- Injectable solutions
Headquarters: Cairo, Egypt
Parent Company: HoldiPharma
Frequently Asked Questions
-
What is Memphis Pharmaceuticals & Chemical Industries's (EGX-MPCI) current market cap?As of 07/05/2025, Memphis Pharmaceuticals & Chemical Industries (including the parent company, if applicable) has an estimated market capitalization of $33.5 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Memphis Pharmaceuticals & Chemical Industries (EGX-MPCI) rank globally by market cap?Memphis Pharmaceuticals & Chemical Industries global market capitalization ranking is approximately 32707 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.